MYOPATHY ASSOCIATED WITH HMG-COA REDUCTASE INHIBITORS (HMGRIS) AND CYCLOSPOSIN-A - EVALUATION IN A RAT MODEL

被引：24

作者：

SMITH, PF

EYDELLOTH, RS

GROSSMAN, SJ

STUBBS, RJ

SCHWARTZ, MS

GERMERSHAUSEN, JI

MACDONALD, JS

机构：

[1] MERCK SHARP & DOHME LTD, DEPT DRUG METAB, West Point, PA 19486 USA

[2] MERCK SHARP & DOHME LTD, DEPT BIOCHEM REGULAT, RAHWAY, NJ 07065 USA

来源：

EUROPEAN HEART JOURNAL | 1992年 / 13卷

关键词：

D O I：

10.1093/eurheartj/13.suppl_B.2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2 / 6

页数：5

共 33 条

[21]

MOSLEY ST, 1989, J LIPID RES, V30, P1411

[22] THE EFFECT OF DRUGS ON BILE-FLOW AND COMPOSITION - AN OVERVIEW [J].

OKOLICSANYI, L ;

LIRUSSI, F ;

STRAZZABOSCO, M ;

JEMMOLO, RM ;

ORLANDO, R ;

NASSUATO, G ;

MURACA, M ;

CREPALDI, G .

DRUGS, 1986, 31 (05) :430-448

[23]

PANDAK WM, 1988, HEPATOLOGY, V8, P1367

[24] MYOPATHY AND RHABDOMYOLYSIS ASSOCIATED WITH LOVASTATIN-GEMFIBROZIL COMBINATION THERAPY [J].

PIERCE, LR ;

WYSOWSKI, DK ;

GROSS, TP .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (01) :71-75

[25]

RYFFEL B, 1983, ARCH TOXICOL, V53, P107

[26]

SCHADE RR, 1983, TRANSPLANT P, V15, P2757

[27] CYCLOSPORINE-A-INDUCED CHOLESTASIS - THE MECHANISM IN A RAT MODEL [J].

STONE, BG ;

UDANI, M ;

SANGHVI, A ;

WARTY, V ;

PLOCKI, K ;

BEDETTI, CD ;

VANTHIEL, DH .

GASTROENTEROLOGY, 1987, 93 (02) :344-351

[28]

Stubbs R., 1990, DRUG INVEST S2, V2, P18, DOI 10.1007/BF03258190

[29] EFFICACY AND LONG-TERM ADVERSE EFFECT PATTERN OF LOVASTATIN [J].

TOBERT, JA .

AMERICAN JOURNAL OF CARDIOLOGY, 1988, 62 (15) :J28-J34

[30]

TOBERT JA, 1990, AM J CARDIOL, V65, pF23

← 1 2 3 4 →